Save the Children, GlaxoSmithKline announce partnership

May 10, 2013 at 4:58 PM   |   0 comments

LONDON, May 10 (UPI) -- Pharmaceuticals manufacturer GlaxoSmithKline and the Save the Children charity announced a partnership to develop medicines to combat child mortality in Africa.

The company said the partnership would set a new standard for how companies and charities can work together.

In reference to Save the Children, Andrew Witty, GlaxoSmithKline executive director, said: "For the first time we're involving a voice from an NGO (non-governmental organization) in our research and development agenda setting, for our pediatric development programs focused on the developing world. A partnership of this scale gives us an opportunity to do something amazing."

Flagship programs will begin in Kenya and the Democratic Republic of Congo, the company said in a release.

Witty said his firm expects to give about $23 million to Save the Children over the next several years.

© 2013 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Trending News
Join the conversation
x
Feedback